J D Sipe

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Review: history of the amyloid fibril
    J D Sipe
    Center for Scientific Review, National Institutes of Health, Maryland, Bethesda, 20892, USA
    J Struct Biol 130:88-98. 2000
  2. ncbi IX International Symposium on Amyloidosis, July 15-21, 2001, Budapest, Hungary
    Jean D Sipe
    Tissue Engineering Study Section, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892-7814, USA
    Amyloid 9:52-65. 2002
  3. ncbi Tissue engineering and reparative medicine
    Jean D Sipe
    Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20814, USA
    Ann N Y Acad Sci 961:1-9. 2002
  4. ncbi Xth International Symposium on Amyloid and Amyloidosis April 18-22, 2004 (selected highlights) Tours, Loire Valley, France
    Jean D Sipe
    Emerita, Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA
    Amyloid 11:268-72. 2004
  5. ncbi Amyloid and amyloidosis. The 2nd Romhányi Memorial Symposium April 24, 2004, Pécs, Hungary
    Jean D Sipe
    Department of Biochemistry, Boston University School of Medicine, Boston, USA
    Amyloid 11:273-5. 2004
  6. ncbi Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis
    Per Westermark
    Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Amyloid 12:1-4. 2005
  7. ncbi XIth International Symposium on Amyloid and Amyloidosis. Marine Biological Laboratory, Woods Hole, Massachusetts, USA, November 5 - 9, 2006
    Jean D Sipe
    Amyloid 14:113-7. 2007
  8. ncbi A primer of amyloid nomenclature
    Per Westermark
    Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Amyloid 14:179-83. 2007

Detail Information

Publications8

  1. ncbi Review: history of the amyloid fibril
    J D Sipe
    Center for Scientific Review, National Institutes of Health, Maryland, Bethesda, 20892, USA
    J Struct Biol 130:88-98. 2000
    ..Chemical and physical definition of the fibrils in tissues will be needed to relate the in vitro properties of amyloid protein fibrils to the pathogenesis of amyloid fibril formation in vivo...
  2. ncbi IX International Symposium on Amyloidosis, July 15-21, 2001, Budapest, Hungary
    Jean D Sipe
    Tissue Engineering Study Section, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892-7814, USA
    Amyloid 9:52-65. 2002
  3. ncbi Tissue engineering and reparative medicine
    Jean D Sipe
    Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20814, USA
    Ann N Y Acad Sci 961:1-9. 2002
    ....
  4. ncbi Xth International Symposium on Amyloid and Amyloidosis April 18-22, 2004 (selected highlights) Tours, Loire Valley, France
    Jean D Sipe
    Emerita, Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA
    Amyloid 11:268-72. 2004
  5. ncbi Amyloid and amyloidosis. The 2nd Romhányi Memorial Symposium April 24, 2004, Pécs, Hungary
    Jean D Sipe
    Department of Biochemistry, Boston University School of Medicine, Boston, USA
    Amyloid 11:273-5. 2004
  6. ncbi Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis
    Per Westermark
    Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Amyloid 12:1-4. 2005
    ..Synthetic fibrils with amyloid properties are best named 'amyloid-like'. With increasing knowledge, however, the borders between different protein aggregates tend to become less sharp...
  7. ncbi XIth International Symposium on Amyloid and Amyloidosis. Marine Biological Laboratory, Woods Hole, Massachusetts, USA, November 5 - 9, 2006
    Jean D Sipe
    Amyloid 14:113-7. 2007
  8. ncbi A primer of amyloid nomenclature
    Per Westermark
    Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Amyloid 14:179-83. 2007
    ..All amyloid types are today preferably named by their major fibril protein. This makes a simple and rational nomenclature for the increasing number of amyloid disorders known in humans and animals...